Disclosures: Jean Damascene Makuza: Nothing to Disclose, Dahn Jeong: Nothing to Disclose, Atul Aravindakshan: Nothing to Disclose, Richard Morrow: Nothing to Disclose, Prince Adu: Nothing to Disclose, Marie Paul Nisingizwe: Nothing to Disclose, Georgine Cua: Nothing to Disclose, Hctor Velsquez Garca: Nothing to Disclose, Janvier Serumondo: Nothing to Disclose, Albert Tuyishime: Nothing to Disclose, Joseph Puyat: Nothing to Disclose, Nothing to Disclose, Joseph Puyat: Nothing to Disclose, Nothing to Disclose, Alnoor Ramji: Nothing to Disclose, Michael Law: Nothing to Disclose, Naveed Janjua: Nothing to Disclose 382 ESTABLISHMENT OF HBX RESPONSIVE QUANTITATIVE CELL CULTURE REPORTER SYSTEM FOR MONITORING HBV INFECTION Muhammad Atif Zahoor 1 Nahla Fadlelmawla 2 Adrian Kuipery 3 Joshua Feld 2 Alexander Mosa 2 Adam Gehring 4 Jordan Feld 5 , 1 University Health Network, Toronto, Canada, 2 Toronto Center for Liver Disease, University Health Network, Toronto, Ontario, Canada, 3 Department of Immunology, University of Toronto, Toronto, Ontario, Canada, 4 University Health Network, 5 Toronto General Hospital Background: Chronic hepatitis B virus (HBV) is a major risk factor for developing liver fibrosis, cirrhosis, and hepatocellular carcinoma
10.1016/J.BRAINRESBULL.2012.09.005 121 MaQ
For infertile patients and those with history of recurrent miscarriage who do not have an underlying autoimmune disease, suppressing the maternal immune system with medications has for the most part not been successful in improving implantation or preventing miscarriage
For diagnostic experiments, the width of the fluidic channel is considered to be 1 mm, providing an 80 L capacity for blood samples
Basu, VEGF-A controls the expression of its regulator of angiogenic functions, dopamine D2 receptor, on endothelial cells
